A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

The company behind popular weight-loss drugs failed to disclose even more ... Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose ...

These drugs aren’t FDA approved ... If you’re being prescribed a medication for weight loss, Zepbound, and Saxenda are FDA approved for weight management and may be used to promote weight ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...